Skip to content

Clinical trials

Phase 2 Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 2 Clear all

188 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20015
20026
20036
200411
20059
20068
20077
20086
20097
20107
20118
20126
20136
20144
20154
20164
201710
20182
20195
20204
20214
20223
20234
20242
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Terminated28
Active, not recruiting14
Withdrawn10
Recruiting8
Unknown status8
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center21
Dana-Farber Cancer Institute19
National Cancer Institute (NCI)10
Mayo Clinic7
Jonsson Comprehensive Cancer Center6
Memorial Sloan Kettering Cancer Center5
Roswell Park Cancer Institute5
Hoag Memorial Hospital Presbyterian4
SWOG Cancer Research Network4
Case Comprehensive Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia188
Lymphoma, B-Cell, Marginal Zone101
Leukemia, Lymphocytic, Chronic, B-Cell99
Lymphoma, Follicular96
Lymphoma, Non-Hodgkin80
Lymphoma, Mantle-Cell78
Lymphoma, Large B-Cell, Diffuse71
Lymphoma68
Precursor Cell Lymphoblastic Leukemia-Lymphoma61
Burkitt Lymphoma59

Trials

Showing 1 to 25 of 188. Each trial links to its page on Pharma Observatory.

88 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.